Peeling Back The Layers: Exploring Teladoc Health Through Analyst Insights
Portfolio Pulse from Benzinga Insights
Teladoc Health (NYSE:TDOC) has been analyzed by 14 analysts, showing a range of perspectives from bullish to bearish. The average 12-month price target is $10.5, down from $16.00. Analysts have adjusted their ratings and price targets, reflecting recent developments. Teladoc faces challenges with revenue growth, net margin, ROE, ROA, and debt management.
October 08, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Teladoc Health has received mixed analyst ratings, with a lowered average price target of $10.5. The company faces challenges in revenue growth, profitability, and debt management.
The article highlights a significant decline in the average price target for Teladoc Health, indicating negative sentiment among analysts. The company's financial challenges, including declining revenue and high debt, further contribute to a likely negative short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100